Identification and characterization of a novel folliculin-interacting protein FNIP2

H Hasumi, M Baba, SB Hong, Y Hasumi, Y Huang… - Gene, 2008 - Elsevier
Birt–Hogg–Dube'syndrome characterized by increased risk for renal neoplasia is caused by
germline mutations in the BHD/FLCN gene encoding a novel tumor suppressor protein …

Renal tumour suppressor function of the Birt–Hogg–Dubé syndrome gene product folliculin

V Hudon, S Sabourin, AB Dydensborg… - Journal of medical …, 2010 - jmg.bmj.com
Background Renal cell carcinoma (RCC) comprises five major molecular and histological
subtypes. The Birt–Hogg–Dubé (BHD) syndrome is a hereditary human cancer syndrome …

Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn

H Hasumi, M Baba, Y Hasumi, M Lang… - Proceedings of the …, 2015 - National Acad Sciences
Folliculin (FLCN)-interacting proteins 1 and 2 (FNIP1, FNIP2) are homologous binding
partners of FLCN, a tumor suppressor for kidney cancer. Recent studies have revealed …

Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome

LS Schmidt, WM Linehan - Nature Reviews Urology, 2015 - nature.com
Abstract Birt–Hogg–Dubé (BHD) syndrome is an inherited renal cancer syndrome in which
affected individuals are at risk of developing benign cutaneous fibrofolliculomas, bilateral …

The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dube syndrome is required for murine B-cell development

M Baba, JR Keller, HW Sun, W Resch… - Blood, The Journal …, 2012 - ashpublications.org
Abstract Birt-Hogg-Dubé (BHD) syndrome is an autosomal dominant disorder characterized
by cutaneous fibrofolliculomas, pulmonary cysts, and kidney malignancies. Affected …

Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling

SB Hong, HB Oh, VA Valera, J Stull, DT Ngo, M Baba… - Molecular cancer, 2010 - Springer
Background Germline mutations in the FLCN gene are responsible for the development of
fibrofolliculomas, lung cysts and renal neoplasia in Birt-Hogg-Dube'(BHD) syndrome. The …

Birt–Hogg–Dube syndrome: clinical and molecular aspects of recently identified kidney cancer syndrome

H Hasumi, M Baba, Y Hasumi… - International journal of …, 2016 - Wiley Online Library
Abstract Birt–Hogg–Dubé syndrome is an autosomal dominantly inherited disease that
predisposes patients to develop fibrofolliculoma, lung cysts and bilateral multifocal renal …

FLCN: the causative gene for Birt-Hogg-Dubé syndrome

LS Schmidt, WM Linehan - Gene, 2018 - Elsevier
Germline mutations in the novel tumor suppressor gene FLCN are responsible for the
autosomal dominant inherited disorder Birt-Hogg-Dubé (BHD) syndrome that predisposes to …

Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies

LS Schmidt - Familial cancer, 2013 - Springer
Since the hallmark dermatologic features of Birt–Hogg–Dubé (BHD) syndrome were first
described by three Canadian physicians in 1977, the clinical manifestations of BHD have …

Birt–Hogg–Dubé syndrome: clinicopathological features of the lung

M Furuya, Y Nakatani - Journal of Clinical pathology, 2013 - jcp.bmj.com
Birt–Hogg–Dubé syndrome (BHD) is an autosomal dominant inherited disorder
characterised by fibrofolliculomas, renal tumours, pulmonary cysts and pneumothorax. The …